found that melatonin treatment of focal cerebral ischemia model rats reduced the expression of plasma exosomal miR-152-5p, and could reduce the inflammatory response after stroke through the TLR4/NF-κB pathway. The gene discussed is NFKB1; the disease is Stroke.